GlassScriptPhysician profile
Patrick M Mcginty
NPI 1912127358
$13,250.95
in general payments reported to CMS, 2019-2025
54 companies · $2,951 in 2025
The $2,951 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,219 · 2020: $404 · 2021: $800 · 2022: $2,471 · 2023: $2,544 · 2024: $1,861 · 2025: $2,951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,356.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,179.78 | 2019-2025 | |
| Pfizer INC. | $1,152.63 | 2019-2025 | |
| Amgen INC. | $760.31 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $712.59 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Merck Sharp & Dohme LLC | $681.11 | 2021-2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $580.47 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $522.88 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $512.04 | 2019-2025 | Watchman Access System, Watchman Flx, Wavewriter Alpha Prime 16 |
| E.R. Squibb & Sons, L.L.C. | $507.42 | 2019-2025 | Camzyos, Eliquis |
| Esperion Therapeutics, INC. | $492.78 | 2021-2025 | Nexletol, Nexlizet |
| Aop Health US, LLC | $463.52 | 2025 | Rapiblyk |
| Cvrx, INC. | $460.61 | 2022-2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $451.44 | 2019-2025 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $437.51 | 2019-2025 | Uptravi, Opsumit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $411.38 | 2019-2025 | Lifevest |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $397.06 | 2019-2025 | Evkeeza |
| Medtronic, INC. | $354.31 | 2023-2025 | Linq II, Aurora Ev-Icd Mri Surescan |
| Kestra Medical Technology Services, INC. | $342.50 | 2024-2025 | Assure Wcd |
| Abbott Laboratories | $334.88 | 2019-2024 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $322.70 | 2021-2025 | Impella |
| Irhythm Technologies, INC. | $279.28 | 2019-2024 | Zio Monitor, Zio Xt Patch |
| Alnylam Pharmaceuticals INC. | $259.87 | 2022-2025 | Amvuttra |
| Medtronic Vascular, INC. | $192.19 | 2019 | |
| Biosense Webster, INC. | $135.05 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $131.78 | 2021-2023 | Arcalyst |
| Bardy Diagnostics, INC. | $115.00 | 2022 | |
| Amarin Pharma, INC. | $113.88 | 2019-2022 | |
| Chiesi USA, INC. | $93.72 | 2022-2025 | Kengreal |
| Kiniksa Pharmaceuticals International, Plc | $75.47 | 2024 | Arcalyst |
| Heartflow, INC. | $75.25 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $69.90 | 2019 | |
| Novo Nordisk INC | $65.04 | 2021-2024 | Rybelsus, Ozempic |
| Impulse Dynamics (USA) INC. | $62.92 | 2022-2023 | Optimizer |
| Baxter Healthcare | $45.22 | 2024-2025 | Hillrom - Cardiac Ambulatory Monitor |
| Philips North America LLC | $43.11 | 2023-2024 | (Ck4) Mcot |
| Gilead Sciences, INC. | $42.48 | 2019 | |
| Lundbeck LLC | $41.79 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $40.77 | 2023-2024 | Inpefa |
| Cleerly, INC. | $27.13 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Biotronik INC. | $24.45 | 2022 | |
| Lilly USA, LLC | $23.75 | 2025 | Mounjaro, Zepbound |
| Atricure, INC. | $20.95 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.63 | 2022 | |
| Daiichi Sankyo INC. | $18.40 | 2022 | |
| Celgene Corporation | $18.17 | 2023 | Camzyos |
| W. L. Gore & Associates, INC. | $17.82 | 2020 | |
| Angiodynamics, INC. | $17.72 | 2021 | |
| Glaxosmithkline, LLC. | $17.59 | 2025 | Shingrix |
| Kowa Pharmaceuticals America, INC. | $15.86 | 2022 | |
| Amryt Pharma Holdings LTD | $15.28 | 2022 | |
| Itamar Medical INC | $14.06 | 2022 | |
| Lantheus Medical Imaging, INC. | $13.88 | 2022 | |
| Tactile Systems Technology INC | $12.65 | 2019 | |
| Allergan, INC. | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mcginty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.